Martek Biosciences Corp., a developer of health and wellness food and supplements, said Thursday it expects to receive a permanent court injunction against a Swiss drug company related to its fatty acid product. Columbia, Md.-based Martek said the U.S. District Court judge in Wilmington, Del., will enter a permanent injunction against Lonza Ltd. marketing its fatty acid product. The decision came in a patent infringement suit against Lonza Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH. Martek said the judge also ruled in favor of two of Martek's three patents for the fatty acid product, sold by Martek under the name life's DHA. Martek filed suit in 2006 after Swiss drug company Lonza began marketing the product under a different name.

Posted by GEN-ERIC at 01:04:46 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/1380

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)